164 related articles for article (PubMed ID: 34610470)
1. PLD1 promotes reactive oxygen species production in vascular smooth muscle cells and injury-induced neointima formation.
Cai M; Wang Z; Luu TTT; Zhang D; Finke B; He J; Tay LWR; Di Paolo G; Du G
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159062. PubMed ID: 34610470
[TBL] [Abstract][Full Text] [Related]
2. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury.
Wang H; Robichaux WG; Wang Z; Mei FC; Cai M; Du G; Chen J; Cheng X
Sci Rep; 2016 Nov; 6():36552. PubMed ID: 27830723
[TBL] [Abstract][Full Text] [Related]
4. Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury.
Kitano T; Usui S; Takashima SI; Inoue O; Goten C; Nomura A; Yoshioka K; Okajima M; Kaneko S; Takuwa Y; Takamura M
Biochem Biophys Res Commun; 2019 Mar; 511(1):179-184. PubMed ID: 30777331
[TBL] [Abstract][Full Text] [Related]
5. Connexin37 reduces smooth muscle cell proliferation and intimal hyperplasia in a mouse model of carotid artery ligation.
Allagnat F; Dubuis C; Lambelet M; Le Gal L; Alonso F; Corpataux JM; Déglise S; Haefliger JA
Cardiovasc Res; 2017 Jun; 113(7):805-816. PubMed ID: 28449099
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
[TBL] [Abstract][Full Text] [Related]
7. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
[TBL] [Abstract][Full Text] [Related]
8. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of quinone reductase 2 attenuates vascular smooth muscle cells proliferation and neointimal formation in balloon injured rat carotid artery.
Zhang XW; Wang Y; Cai JB; Hou XF; Wang HG; Zou JG; Cao KJ
Cell Physiol Biochem; 2012; 29(3-4):453-62. PubMed ID: 22508052
[TBL] [Abstract][Full Text] [Related]
10. Deletion of MFGE8 Inhibits Neointima Formation upon Arterial Damage.
Viola JR; Lemnitzer P; Paulin N; Drechsler M; Nazari-Jahantigh M; Maas S; De Jong RJ; Winter J; Schober A; Weber C; Atabai K; Soehnlein O
Thromb Haemost; 2018 Jul; 118(7):1340-1342. PubMed ID: 29864782
[No Abstract] [Full Text] [Related]
11. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
Yang J; Li S; Wang Q; Yang D
Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
[TBL] [Abstract][Full Text] [Related]
12. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
14. KLF13 promotes VSMCs phenotypic dedifferentiation by directly binding to the SM22α promoter.
Yuan X; Jiang C; Xue Y; Guo F; Luo M; Guo L; Gao Y; Yuan T; Xu H; Chen H
J Cell Physiol; 2024 May; 239(5):e31251. PubMed ID: 38634445
[TBL] [Abstract][Full Text] [Related]
15. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Tzeng BH; Chen YH; Huang CH; Lin SS; Lee KR; Chen CC
Cardiovasc Res; 2012 Dec; 96(3):533-42. PubMed ID: 22886848
[TBL] [Abstract][Full Text] [Related]
16. Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells.
Wang JN; Shi N; Chen SY
Free Radic Biol Med; 2012 Jan; 52(1):173-81. PubMed ID: 22062629
[TBL] [Abstract][Full Text] [Related]
17. Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation.
Wang Y; Xu Y; Yan S; Cao K; Zeng X; Zhou Y; Liu Z; Yang Q; Pan Y; Wang X; Boison D; Su Y; Jiang X; Patel VS; Fulton D; Weintraub NL; Huo Y
Cardiovasc Res; 2021 Jan; 117(2):561-575. PubMed ID: 32065618
[TBL] [Abstract][Full Text] [Related]
18. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
[TBL] [Abstract][Full Text] [Related]
19. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
20. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia.
Niu K; Zhang C; Yang M; Maguire EM; Shi Z; Sun S; Wu J; Liu C; An W; Wang X; Gao S; Ge S; Xiao Q
Cardiovasc Res; 2024 May; 120(7):796-810. PubMed ID: 38498586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
